Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
122,938,515
-
Share change
-
-2,969,548
-
Total reported value
-
$35,007,055,136
-
Put/Call ratio
-
109%
-
Price per share
-
$284.85
-
Number of holders
-
978
-
Value change
-
-$823,600,550
-
Number of buys
-
390
-
Number of sells
-
437
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q2 2023
As of 30 Jun 2023 BIOGEN INC. - COM (BIIB) had 978 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 122,938,515 shares of stock of the company.
Largest 10 holders included PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, T. Rowe Price Investment Management, Inc., GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, and Clearbridge Investments, LLC.
This table shows 992 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.